Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
HIV drug research in Wales to cut infection risk

Nearly 400 people have been taking part in a three-year trial of the drugs in Wales since last summer. Cardiff University will now examine how people have been taking the medicine - and if that affects the protection.

Published
12 hours ago
From
BBC
Privilege and Profit Corrupt the PrEP Access Debate

If most folks are getting their PrEP for free, then who cares what Gilead charges? Peter Staley explains why ALL of us should care.

Published
15 August 2018
From
Poz
People taking HIV-prevention pill may get more primary care

When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.

Published
15 August 2018
From
Reuters
Declining HIV numbers bolstered by new prevention drug but more data needed

Changes to HIV medications are on the horizon just a few months after New Zealand became one of the first countries to publicly fund a "revolutionary" prevention drug. National regulator Pharmac has begun a three-week tender process for a selection of antiretroviral treatments (ARTs) to be provided to hospitals and community pharmacies around the country.

Published
13 August 2018
From
Stuff.nz
Why Do Some Gay and Bi Men Stigmatize PrEP Users?

A focus-group-based study parsed men’s attitudes about pre-exposure prophylaxis.

Published
10 August 2018
From
Poz
PrEP scales up, HIV incidence declines

As use of PrEP continues to grow, epidemiological evidence is starting to show a link between increased use and declines in new HIV infections.

Published
09 August 2018
From
BETA blog
New Zealand: Pharmac widens access to 'revolutionary' HIV-prevention drug

Hundreds of prescriptions for a "revolutionary" HIV-prevention drug have been approved in the first few months of it being more widely available. Pharmac expanded access to Truvada in March. In the first three months, 695 people got the medication for the first time, paying $5 for a three-month prescription.

Published
08 August 2018
From
Newshub
Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

The commercial, aptly titled "I'm on the Pill," is part of a marketing push that has helped turned the use of Truvada for preventing HIV into a $1.3 billion blockbuster, almost 5% of Gilead's annual sales.

Published
07 August 2018
From
Forbes Magazine
Thailand brings PrEP to scale

Thailand is starting to roll out pre-exposure prophylaxis (PrEP) for HIV prevention among key higher-risk groups in high burden provinces, scaling up PrEP pilot projects within the national health system. The announcement was made at the satellite session “Breaking barriers and building bridges toward sustainability of the AIDS response in South-East Asia” during the International AIDS Conference in Amsterdam, Netherlands.

Published
02 August 2018
From
UNAIDS
The perception of PrEP as an excuse for promiscuity

A new study sought to deconstruct the moral debate surrounding biomedical HIV prevention and the complex ways in which PrEP and PrEP users are defined within the gay and bisexual communities. The study examined the stereotypes attributed to PrEP users and how these stereotypes contribute to framing the use of PrEP by some as a social problem. The findings were published in Sociology of Health & Illness.

Published
02 August 2018
From
Medical Xpress
← First12345...113Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.